From July 1, 2023 to August 14, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on August 15, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.35 USD | +10.33% | +33.14% | +30.85% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.85% | 9.11M | |
+22.94% | 46.4B | |
-1.71% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.14% | 26.01B | |
-18.82% | 19.52B | |
+28.65% | 12.43B | |
+0.34% | 12.18B | |
-0.33% | 12.13B |
- Stock Market
- Equities
- PSTV Stock
- News Plus Therapeutics, Inc.
- Tranche Update on Plus Therapeutics, Inc.'s Equity Buyback Plan announced on August 15, 2022.